603077 Sichuan Hebang Biotechnology
- 2.32
- -0.03-1.28%
Sichuan Hebang Biotechnology News
Hebang Biotech (603077): Gimu's net profit +83% month-on-month, plans to repurchase 2-4 billion dollars to show confidence in development
Hebang Biotech (603077): 2023H1 profits are under pressure to invest in Indonesia's alkali and glyphosate projects
Hebang Biotech (603077) Company Information Update Report: Record High Performance Steadily Promoting Glyphosate Projects and PV Industry Layout
Hebang Biotech (603077): Big orders for silicon wafers land, and the volume of photovoltaic materials is rapidly increasing
Hebang Biotech (603077): Interim results exceeded expectations, N-type silicon wafers and diglyphosine projects progressed smoothly
Hebang Biotech (603077): Main business boom continues, PV layout is about to be released
Information update report of Hebang Biological (603077) Co., Ltd.: China News predicts that the N-type single crystal silicon wafer project will help growth.
Hebang Biotech (603077): Outstanding resource endowment advantages, and the layout of the photovoltaic sector is progressing gradually
Hebang Biotech (603077) Company Comment: Interim Report Performance Exceeded Expectations and Projected Valuation of PV Materials Production in the Third Quarter contributed to growth
Hebang Biotech (603077): Soda Ash and Ammonium Chloride Markets Remain Strong, Investing in 500,000 Tons of Intermediate Glyphosine Project
Information update report of Hebang Biology (603077): the performance reached a record high and continued to improve from January to February 2022.
Hebang Biotech (603077) Company Information Update Report: Company Performance Reaches Record High Platform Layout Growth Can Be Expected
Hebang Biology (603077): product price increase superimposed cost advantage company performance may reach an all-time high
Hebang Biotech (603077)'s first coverage report: Continued boom in the main business, the entry into photovoltaic materials and the valuation of photovoltaic materials contributed to growth
Hebang Biotech (603077): The price increase of diglyphose and elasticity highlights the company's growth when glass and methionine are put into production
Hebang Biology (603077): benefit from soda ash, glass and glyphosate price increases add methionine project to photovoltaic glass expansion
Hebang Biology (603077): with the advent of the peak season, new projects have been put into production one after another.
Hebang Biology (603077): high increase in real estate construction pull soda ash boom double glyphosate technical transformation, methionine new project is expected to bring performance increment
Hebang Biology (603077) comments: soda ash, glyphosate business profitability significantly improve methionine, carbon fiber and other new projects make steady progress
Hebang Biology (603077) Annual report and Quarterly report comments: the profits of various businesses have improved significantly in the first quarter.
No Data
